Literature DB >> 6414048

TxA2 production by human arteries and veins.

G G Neri Serneri, R Abbate, G F Gensini, A Panetta, G C Casolo, M Carini.   

Abstract

Human arterial and venous segments from patients under-going operations when incubated in Tris buffer both alone and with arachidonic acid were able to produce thromboxane B2 (assessed by radioimmunoassay). Thromboxane B2 (TxB2) production was progressive in time (till 40 min.) and was enhanced by the addition of 1mM norepinephrine. Contamination of tissues by platelet was checked and platelets did not contribute to thromboxane formation. The investigation of the conversion of 1-14C arachidonic acid by vascular tissue indicated that human vascular tissues produce the metabolites of the cyclooxygenase dependent pathway and that prostacyclin is the main metabolite with a PGI2/TxA2 ratio of 4:1. The arterial wall was found to possess an active lipoxygenase dependent pathway. Thromboxane production by intimal cells was negligible and the main source of thromboxane was the media. The production of thromboxane did not change in relation to age, but arterial segments from men produced significantly larger amounts of thromboxane than those from women.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6414048     DOI: 10.1016/0090-6980(83)90001-1

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  8 in total

1.  Augmented contraction of the human isolated coronary artery by sumatriptan: a possible role for endogenous thromboxane.

Authors:  A Maassen VanDenBrink; W A Bax; M D Ferrari; F J Zijlstra; E Bos; P R Saxena
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

2.  Thromboxane receptor density is increased in human cardiovascular disease with evidence for inhibition at therapeutic concentrations by the AT(1) receptor antagonist losartan.

Authors:  S D Katugampola; A P Davenport
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

3.  The effects of using a leukocyte removal filter during cold blood cardioplegia.

Authors:  T Ichihara; K Yasuura; T Maseki; A Matsuura; K Miyahara; T Ito; S Kato; S Mizuno; S Tamaki; A Seki
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

Review 4.  Selenium and selenoproteins in prostanoid metabolism and immunity.

Authors:  Fenghua Qian; Sougat Misra; K Sandeep Prabhu
Journal:  Crit Rev Biochem Mol Biol       Date:  2020-01-30       Impact factor: 8.250

5.  GPCR-mediated EGF receptor transactivation regulates TRPV4 action in the vasculature.

Authors:  Mahmoud Saifeddine; Mahmoud El-Daly; Koichiro Mihara; Nigel W Bunnett; Peter McIntyre; Christophe Altier; Morley D Hollenberg; Rithwik Ramachandran
Journal:  Br J Pharmacol       Date:  2015-03-18       Impact factor: 8.739

Review 6.  Approaches to prevention of cardiovascular complications and events in diabetes mellitus.

Authors:  Sergio Coccheri
Journal:  Drugs       Date:  2007       Impact factor: 9.546

7.  The role of endogenous thromboxane in contractions to U46619, oxygen, 5-HT and 5-CT in the human isolated umbilical artery.

Authors:  A G Templeton; J C McGrath; M J Whittle
Journal:  Br J Pharmacol       Date:  1991-05       Impact factor: 8.739

8.  Resolvin D1 Enhances Necroptotic Cell Clearance Through Promoting Macrophage Fatty Acid Oxidation and Oxidative Phosphorylation.

Authors:  Zeinab Hosseini; Michael Marinello; Christa Decker; Brian E Sansbury; Sudeshna Sadhu; Brennan D Gerlach; Ramon Bossardi Ramos; Alejandro P Adam; Matthew Spite; Gabrielle Fredman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-01-21       Impact factor: 8.311

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.